Re-Evaluate Alteplase Contraindications in Your Stroke Protocol

You'll hear controversy about whether more patients should receive alteplase (Activase) for acute ischemic stroke.

Changes in labeling suggest broadening the scope of stroke patients who should get alteplase. But this is due to new rules designed to simplify labeling...not new evidence.

Now the Am Heart and Stroke Associations are weighing in...saying yes to using alteplase in more patients...but with a few cautions.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals